子宫肌瘤子宫切除术临床路径患者住院费用影响因素分析  

Analysis on the medical expenses′ influencing factors of the clinical pathway inpa-tients with myoma of uterus hysterectomy

作　　者：郝丽霞[1] 闫曙光[1] 费丽萍[1] 王珮瑄[1] 安艳艳[1] 

机构地区：[1]长治医学院附属和济医院,山西长治046000

出　　处：《国际护理学杂志》2016年第4期451-456,共6页international journal of nursing

基　　金：山西省长治市科技项目（20113015）Fund program：Scientific and Technological Project of Changzhi, Shanxi Province

摘　　要：目的：分析子宫肌瘤子宫切除术临床路径患者住院费用的相关影响因素。方法选择某三级甲等医院2012~2014年3年间子宫肌瘤子宫切除术临床路径患者380例,应用SPSS软件进行方差分析、Logistic回归方程等统计学分析。结果3年的住院平均费用呈逐年增高趋势（F=12.71,P〈0.01）,住院日、医疗付费方式、药费、手术费是影响子宫肌瘤子宫切除术临床路径患者住院费用的主要因素（ P〈0.01）。结论控制住院费用的关键仍在于缩短住院日、确定适宜的医疗付费比例、降低药费和手术费用上,建议继续科学研制临床路径,丰富我国本土化DRGs预付费体系。Objective To analyze the related influencing factors of inpatients with clinical pathway with myo-ma of uterus hysterectomy. Methods From 2012 to 2014 , a total of 380 cases of clinical pathway inpatients with myo-ma of uterus hysterectomy were selected from a Class III Grade I hospital. The SPSS statistical software was used for ANOVA and Logistic Regression. Results During the 3 years, the average cost of hospitalization had been increasing gradually （ F=12. 71 , P〈 0. 01 ） , the major factors that influenced the hospitalization expenses of clinical pathway in-patients with myoma of uterus and hysterectomy include hospitalization duration, medical payments , expenses for medi-cine and operation fee （ P〈0. 01 ） . Conclusion The key to control the hospitalization expenses lies in shortening the hospitalization duration, setting up appropriate proportion of medical payment, reducing the expenses for medicine and operation fee. It is strongly recommended that the clinical pathway should be implemented scientifically and the localized DRGs pre-paid system suitable for Chinese conditions should be enriched gradually.

关 键 词：子宫肌瘤 临床路径 住院费用 影响因素 

分 类 号：R713.42[医药卫生—妇产科学]